It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
CD59 is an abundant immuno-regulatory receptor that protects human cells from damage during complement activation. Here we show how the receptor binds complement proteins C8 and C9 at the membrane to prevent insertion and polymerization of membrane attack complex (MAC) pores. We present cryo-electron microscopy structures of two inhibited MAC precursors known as C5b8 and C5b9. We discover that in both complexes, CD59 binds the pore-forming β-hairpins of C8 to form an intermolecular β-sheet that prevents membrane perforation. While bound to C8, CD59 deflects the cascading C9 β-hairpins, rerouting their trajectory into the membrane. Preventing insertion of C9 restricts structural transitions of subsequent monomers and indirectly halts MAC polymerization. We combine our structural data with cellular assays and molecular dynamics simulations to explain how the membrane environment impacts the dual roles of CD59 in controlling pore formation of MAC, and as a target of bacterial virulence factors which hijack CD59 to lyse human cells.
CD59 protects human cells from damage by the MAC immune pore. The authors show how CD59 inhibits MAC, by deflecting pore-forming β-hairpins of complement proteins. As well as how the membrane environment influences the role of CD59 in complement regulation and in host-pathogen interactions.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details



1 Imperial College London, Department of Life Sciences, Sir Ernst Chain Building, London, United Kingdom (GRID:grid.7445.2) (ISNI:0000 0001 2113 8111)
2 Imperial College London, Department of Life Sciences, Sir Ernst Chain Building, London, United Kingdom (GRID:grid.7445.2) (ISNI:0000 0001 2113 8111); Imperial College London, Department of Chemistry, Molecular Sciences Research Hub, London, United Kingdom (GRID:grid.7445.2) (ISNI:0000 0001 2113 8111)
3 The University of Warwick, School of Life Sciences and Department of Chemistry, Gibbet Hill Campus, Coventry, United Kingdom (GRID:grid.7372.1) (ISNI:0000 0000 8809 1613)
4 Imperial College London, Department of Chemistry, Molecular Sciences Research Hub, London, United Kingdom (GRID:grid.7445.2) (ISNI:0000 0001 2113 8111)